Revised prices will come into effect from November 9, 2026, following trade margin rationalisation of 137 non-scheduled ...

The Department of Pharmaceuticals has reviewed 4,283 physical files and 20 e-files, weeded out 489 files and freed 2,200 square feet of office space during the campaign ...

The projects will focus on investigational therapies for advanced keratopathy and wet age-related macular degeneration, with ...

Dr Ravi K V, Assistant Professor, Department of Kriya Sharira, SDM College of Ayurveda Hospital and Research Centre, Udupi, ...

The six-day programme, organised by FABA with academic and industry partners, covers medicinal chemistry, AI-based drug ...

The approval authorises the CRO to conduct bioavailability and bioequivalence studies for submission to Brazil, with ...

The name change takes effect on October 28, 2026, with no changes to ownership, management, operations, products or services ...

What gaps in India’s dermatology and skincare market led to the creation of Puresta, and how does the company plan to build a ...

Acquisition adds a 30,000 sqm pharmaceutical platform to Messe Muenchen India’s portfolio,  connecting research, ...

The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil ...

The deal will give Mankind Pharma access to a pipeline of CAR-T therapies for cancer, including programmes targeting ...

The partnership will cover technology transfer, clinical manufacturing and commercial production of VeGen Bio’s VL-2511 in ...